The Economist on Friday published two articles from Saturday’s print edition regarding the XIX International AIDS Conference (AIDS 2012). One article states that “[f]ew areas of international affairs have seen more recent success than the fight against AIDS,” and discusses advancements in HIV treatment research and availability (7/28). A second article provides a recap of several studies presented at the conference, notes “some people are starting to look beyond [current] antiretroviral (ARV) drugs,” and writes, “Several clues suggest a cure may be possible” (7/28). In a related post, the Economist’s “Babbage” blog reports on new tuberculosis (TB) research presented at the conference on Monday, which “found that a combination of one experimental drug, one drug approved for other infectious diseases and one existing TB drug had a comparable effect to standard TB treatment,” suggesting “the combination may fight some TB strains resistant to other drugs — and do so quite quickly” (7/26).
Global Health Conferences and Meetings
At the XIX International AIDS Conference (AIDS 2012) on Thursday, PEPFAR and Becton, Dickinson and Company (BD), “announced Labs for Life, a new collaboration to help strengthen healthcare and laboratory systems in the developing world along with U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (CDC),” a State Department fact sheet states (7/26). “The new five-year initiative builds on a previous five-year partnership between the U.S. government and [BD]” that “improved lab services in sub-Saharan African countries affected by HIV/AIDS and tuberculosis, according to U.S. officials who had been briefed on an audit that will be released in a few weeks,” CQ HealthBeat reports (Adams, 7/26).
Two studies presented at the XIX International AIDS Conference (AIDS 2012) and one published Wednesday in the British journal Nature “have given researchers renewed hope that a cure for AIDS may be possible,” the Washington Post reports. “None of the strategies are easy, proved or ready for prime time,” but “all involve procedures or drugs that are already in use and are able to be deployed widely if further research bears out the early findings,” the newspaper writes (Brown/Botelho, 7/26). “One study focused on a group of 12 patients in France who began treatment on antiretroviral drugs within 10 weeks of becoming infected with human immunodeficiency virus, but then stopped the therapy” after an average of three years of treatment, Agence France-Presse writes (Sheridan/Santini, 7/26). According to a conference press release, the patients “have shown no signs of a resurgence of their HIV infection” six years after stopping therapy (7/26). “The work is further evidence that people should be given drugs as soon as possible,” the Guardian adds (Boseley, 7/26).
WEBCAST: Kaiser Family Foundation Interviews Science's Jon Cohen Regarding New Research On HIV Treatment In East Africa
“Science Magazine’s Jon Cohen speaks with the Kaiser Family Foundation’s Jackie Judd about preliminary science that may show why East Africans could be at a disadvantage when being treated for HIV infection,” in a “Washington Notebook” interview on the foundation’s webpage, PBS NewsHour reports. Cohen discusses two studies presented at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., this week (7/25).
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship “focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS,” the Center for Global Health Policy’s “Science Speaks” blog reports (Mazzotta, 7/25). During the session, Rubio “expressed strong support for foreign aid, especially funding to combat HIV/AIDS,” and Lee “recounted with Frist the history of U.S. efforts to provide global funding,” CQ HealthBeat reports (Adams, 7/25). “‘We have to keep our eyes on the prize,’ and focus on moving forward and figuring out how to work together in a bipartisan way. It happened in the past, [Lee] said, and we can do it again,” “Science Speaks” writes (7/25). Coons “recommended the United States ‘double down’ on investments for AIDS,” in order to “‘innovate and cure our way out of this. That, I think, is in keeping with the optimism and the entrepreneurship of the American character,’ added Mr. Coons,” the Washington Times notes. The discussion was “punctuated by protesters with red umbrellas and signs calling for an end to the ‘criminalization’ of sex workers, drug addicts and other marginalized groups with AIDS,” the Washington Times writes (Wetzstein, 7/25).
On the sidelines of the XIX International AIDS Conference (AIDS 2012), Georgetown University hosted a conference for faith-based organizations and leaders to come together to discuss their efforts to respond to the HIV/AIDS epidemic, the Washington Post reports. Speaking at the conference, Saddleback Church pastor Rick Warren, “considered one of the country’s leading evangelicals on fighting AIDS, said he was willing to work with anyone ‘who wants to end AIDS,’ but blamed the government for trying to get traditional faith workers to what he called ‘change’ their anti-abortion views in order to partner,” according to the newspaper. “Multiple speakers agreed that Christian churches are indispensable in the AIDS fight,” the newspaper notes (Boorstein, 7/25). In a separate article, the Washington Post notes that Warren’s wife, Kay Warren, spoke at the conference on a panel of religious leaders from all over the globe who “discussed the evolution of faith-based organizations’ thinking on AIDS and HIV since the epidemic began” (Bahrampour, 7/24).
The following webcasts are now available at http://www.kff.org/AIDS2012.
In a post in KPLU’s “Humanosphere” blog, journalist Tom Paulson discusses the role of faith-based organizations in the response to HIV/AIDS, writing, “PEPFAR is mentioned in perhaps every other speech here at the International AIDS Conference, AIDS 2012, as one of those game-changers. Infrequently, some folks also mention, usually just in passing, something like the ‘contributions of the faith-based community.’ What’s probably not appreciated is that U.S. leadership in responding to the global AIDS pandemic came together thanks to an unusual partnership of evangelical Christians and very secular AIDS activists, isolationist conservatives and bleeding-heart liberals” (7/25).
The Center for Global Health Policy’s “Science Speaks” blog reports on a session held on Tuesday at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., titled “Strategic Use of Resources: Doing the Right Things with the Right Money.” According to the blog, “Representatives of three countries and two donors described opportunities and challenges to making the most of scientific advances — and limited funds” in their responses to HIV/AIDS (Barton, 7/25).
“A new tax on financial transactions is set to launch in France in August, and could generate billions of dollars to help fund the global fight against HIV/AIDS,” the Center for Global Health Policy’s “Science Speaks” blog reports. “‘We want to create additional innovative financing instruments. This is the aim of the tax on financial transactions which my country has decided to implement from 1 August 2012,’ said French President Francois Hollande, who spoke via pre-recorded video message at the plenary session of the International AIDS Conference in Washington Monday,” the blog notes (Mazzotta, 7/25).